deep-dive 两款国产ADC改写小细胞肺癌治疗格局：死亡风险各降 54%，为什么不能直接比？ Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-09-14/b7h3_sclc_dual_adc_wclc/wechat_publish.md.
deep-dive 刚拿下胰腺癌，又攻入头号杀手肺癌：首个泛RAS药的代际跨越 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-09-03/daraxonrasib_panras_lungcancer/wechat_publish_ready.html.
deep-dive 当CAR-T不再需要体外培养：中国团队连登NEJM，揭开体内原位重编程的自免革命 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-09-02/invivo_cart_autoimmune/wechat_publish_ready.html.
deep-dive 胰腺癌患者等到6236：不只是FDA批准，也是pan-RAS破局 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-08-26/fdapancreatic/wechat_publish_ready.md.
deep-dive 从失败半个世纪到三期阳性：mRNA 癌症疫苗是怎样做出来的 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-08-18/moerna_2/wechat_publish_ready.md.
deep-dive 个性化mRNA癌症疫苗III期阳性：风险比仍缺席 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-08-18/Moderna/wechat_publish_ready.md.
deep-dive 阿斯利康 PD-1/CTLA-4 双抗 III 期终止：剂量妥协与靶点底色的双重考验 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-08-18/az_volrustomig_p3_failure/wechat_draft_publish.md.
deep-dive 从「没药了才打」到「一开始就要讨论」：诺华这款前列腺癌核药又往前走了一步 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-08-03/pluvicto_psmaddition_mhspc/wechat_draft_v2.md.
deep-dive 82%缓解率之后：通用型CD7 CAR-T要过的下一关 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-07-31/universal_cd7_cart_becar7/wechat_draft_v2.md.
deep-dive 强生 / Sail：体内 CAR-T 的期权竞赛开始了 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-07-30/jnj_sail_invivo_cart/wechat_publish.md.
deep-dive 阿斯利康 Sone-Ve：OS 过了线，CLDN18.2 后线还远没画完 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-07-28/az_sone_ve_clarity_gastric01/wechat_publish.md.
deep-dive 肝癌 CAR-T 上了 Nature：44% 缓解很好看，4.4 个月也要一起读 Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-07-24/abelzeta_gpc3_armored_cart/wechat_publish_v4.html.
deep-dive HR 0.11之后：强生双抗前移，骨髓瘤 CAR-T 还有多少空间？ Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-07-23/jnj_tecvayli_talvey/wechat_publish_v1.html.
deep-dive 康方/Summit 的 PD-1/VEGF 双抗，离 FDA 批准还有多远？ Lumina Research synced content from 06_DailyIntel/03_Daily_Output/daily_drafts/2026-07-22/ivonescimab_fda_hard_test/wechat_publish_v2.html.
